INTRODUCING LYMESCAN™

 Advanced Diagnostic & Therapeutic Care for Lyme and Vector-Borne Illness

Lyme disease and its associated co-infections remain among the most misunderstood and underdiagnosed health crises of our time. Patients suffering from persistent fatigue, cognitive decline, joint pain, neurological shifts, or autoimmune symptoms often endure years of misdiagnoses and ineffective treatments.

THE PROBLEM WITH LYME: WHY STANDARD CARE OFTEN FALLS SHORT

Conventional Lyme diagnostics rely heavily on outdated, insensitive tests and rigid definitions of disease progression. Most physicians are trained to recognize only early-stage Lyme through the presence of a rash or acute symptoms—missing the widespread reality of chronic or “hidden” infections that persist long after exposure.

Dr. Letitia’s research and clinical work have consistently revealed that Borrelia (the Lyme bacterium) can evade both the immune system and conventional detection by transforming into cystic forms or embedding in biofilms. Co-infections such as Bartonella and Babesia further complicate diagnosis, often manifesting as psychiatric symptoms, autoimmune markers, or nonspecific inflammation.

LYMESCAN addresses this diagnostic gap—combining advanced ultrasound imaging with deep clinical evaluation to deliver precise, personalized, and timely care.

---

WHAT MAKES LYMESCAN DIFFERENT?

1. Precision Imaging by Dr. Bard

Using high-resolution Doppler and elastography ultrasound, Dr. Bard brings cutting-edge tools to visualize signs of infection-related inflammation, tissue damage, vascular changes, and subdermal abnormalities often missed in standard evaluations. Imaging areas like joints, skin, lymph nodes, and soft tissues allows for real-time insights into where and how pathogens may be affecting the body.

 

2. Expert Clinical Investigation by Dr. Letitia

Dr. Letitia conducts a comprehensive clinical workup, including an exhaustive history of symptoms, prior exposures, travel, co-infections, mold exposure, immune history, and viral reactivations. Her protocols go beyond checklists—integrating molecular testing, immune panels, and even therapeutic “challenge” regimens to uncover hidden infections.

 

3. Whole-Person Diagnostic Strategy

Where most practices stop at lab reports, LYMESCAN investigates the full story. By combining clinical intuition, advanced imaging, and laboratory diagnostics, the program addresses both active infections and the systemic aftermath of past disease—empowering each patient with answers tailored to their physiology.

To be continued:

The Hormonal Havoc of Lyme Disease: A Diagnostic Dilemma By: Dr. Angela Mazza Lyme disease often presents with subtle and nonspecific symptoms that can complicate timely diagnosis, which leads to patient frustration on many levels. Early signs may include fatigue, brain fog, joint pain, mood changes, and disrupted sleep—symptoms that can easily be mistaken for lots of conditions - ie. stress, hormone imbalance, or autoimmune disorders. Compounding the challenge, standard testing methods such as ELISA and Western blot may lack sensitivity in early or chronic stages, leading to false negatives. From an endocrine standpoint, Lyme disease can provoke systemic inflammation and immune dysregulation, disrupting the hypothalamic-pituitary-adrenal (HPA) axis. This chronic inflammatory state may alter cortisol rhythms, impair thyroid function, and contribute to estrogen and progesterone imbalances, particularly in women. Such endocrine disruptions can further perpetuate fatigue, anxiety, menstrual irregularities, and cognitive dysfunction, creating a complex clinical picture that blurs the lines between infectious, autoimmune, and hormonal conditions.  Having better and earlier strategies for diagnosis is not only important, it is essential!

FROM THE FRONT LINES

As the Northeast enters its annual tick season—typically from April through September—residents face heightened risk of Lyme disease, transmitted by blacklegged ticks (Ixodes scapularis). A Dartmouth meta‑analysis found that approximately 50% of adult deer ticks in Northeastern states such as New York, Connecticut, New Hampshire, Vermont, and Maine harbor Borrelia burgdorferi, with infection rates in nymphs reaching up to 25%.  Nymphs, though smaller and often overlooked, are responsible for most human transmissions during late spring and early summer .

In 2023, the Centers for Disease Control recorded over 89,000 reported Lyme cases nationwide, with the Northeast and Mid‑Atlantic accounting for nearly all high‑incidence regions cdc.gov / epa.gov  With these realities in mind, LYMESCAN’s integrated diagnostic and therapeutic program is both timely and essential, offering advanced imaging, expert clinical insight, and mental‑health support tailored for those navigating this complex public‑health challenge.

---

 

WHO IS LYMESCAN FOR?

·   Individuals with persistent, unexplained symptoms including fatigue, brain fog, joint pain, or neuropathy

·   Patients previously treated for Lyme disease who suspect relapse or co-infection

·   Individuals misdiagnosed with autoimmune or psychiatric conditions but suspect an infectious trigger

·   Families seeking care for children with sudden behavioral, mood, or developmental changes

·   People with known mold exposure, long COVID, or immune dysfunction who now suffer new symptoms

 

 

MORE THAN DIAGNOSIS: A PATH FORWARD

At LYMESCAN, we believe every patient deserves more than a label. Our mission is to empower individuals through knowledge, validation, and targeted care. Through our partnership, Dr. Letitia provides integrative therapeutic strategies, including immune modulation, detoxification support, herbal and pharmaceutical antimicrobials, and guidance on lifestyle changes to restore systemic balance. Dr. Bard contributes ongoing imaging feedback to monitor treatment response, catch early relapses, and guide next steps.

 

 

THE NEXT GENERATION OF LYME CARE IS HERE

Whether you are still searching for answers, or seeking more advanced tools after incomplete treatments elsewhere, LYMESCAN offers a smarter, science-driven solution. Our program is built for the patients that others overlook—because we believe no one should have to suffer in the shadows.

 

 

LYME DISEASE EDUCATION: EMPOWERING THROUGH UNDERSTANDING

At LYMESCAN™, education is at the heart of healing. We believe that patients, caregivers, and healthcare providers alike deserve accurate, up-to-date knowledge about Lyme disease and the broader landscape of vector-borne infections.

Lyme disease is not just a rash and joint pain—it is a complex, evolving illness that can affect the brain, heart, nervous system, and immune response. It can mimic conditions such as chronic fatigue syndrome, multiple sclerosis, depression, and autoimmune disorders. Many patients are left misdiagnosed or untreated simply because practitioners are unaware of the disease’s chronic and multifaceted nature.

Through educational seminars, practitioner outreach, and patient resources, LYMESCAN is committed to raising awareness about:

·   The biology of Borrelia and its ability to evade immune detection

·   Co-infections like Bartonella, Babesia, and Anaplasma that alter disease progression

·   The role of biofilms, cystic forms, and immune suppression in chronic illness

·   Modern tools for accurate diagnosis and symptom monitoring

·   The importance of early detection and comprehensive care

We strive to close the knowledge gap and empower every patient with the facts they need to advocate for their health. Education isn’t optional—it’s essential.

MEET THE LYMESCAN™ TEAM

Uniting Innovation, Clinical Precision, and Compassionate Mental Health Care

LYMESCAN™ brings together a powerhouse team of medical professionals with a shared mission: to transform the way Lyme disease and chronic infections are diagnosed, understood, and treated.

Dr. Robert L. Bard is a globally recognized authority in advanced diagnostic imaging. With decades of experience in functional ultrasound, elastography, and vascular analysis, Dr. Bard is at the forefront of identifying subclinical inflammation, tissue abnormalities, and infectious footprints. His noninvasive imaging strategies bring clarity to complex conditions—offering real-time visuals that validate symptoms and guide precision care.

Dr. Jennifer Letitia is a distinguished integrative physician renowned for her expertise in chronic Lyme disease, mold toxicity, post-viral syndromes, and immune dysregulation. Known for her methodical, whole-body evaluations, Dr. Letitia combines clinical intuition with deep diagnostic science to uncover the root causes of unexplained illness. Her protocol blends advanced testing, symptom-based analysis, and therapeutic interventions grounded in both conventional and naturopathic medicine.

Dr. Barbara Bartlik completes the triad as an esteemed integrative psychiatrist and functional mental health specialist. With vast experience in trauma-informed care, neuropsychiatry, and mind-body medicine, Dr. Bartlik addresses the emotional and cognitive toll of chronic illness. From depression and anxiety to Lyme-induced neurological symptoms, she helps patients restore emotional resilience and psychological balance while working in tandem with the medical team.

Together, this interdisciplinary alliance delivers a truly 360-degree model of care, ensuring no symptom is dismissed and no patient is left behind.

Book a LYMESCAN consultation today and take your first step toward true healing. Clinical appointments available in-person or via referral. For more information, visit www.LymeScan.org

---

Exploring the Link Between Lyme Disease and Hashimoto’s Thyroiditis

The Overlap of Autoimmunity, Infection, and Diagnostic Innovation

Emerging research points to a potential relationship between Lyme disease—a tick-borne infection caused by Borrelia burgdorferi—and Hashimoto’s thyroiditis, an autoimmune disorder in which the immune system mistakenly targets the thyroid gland. Though the link is still being actively investigated, multiple clinical observations suggest that chronic infections like Lyme may play a role in triggering or aggravating autoimmune thyroid dysfunction.

Lyme Disease as a Potential Autoimmune Trigger

Lyme disease can initiate a strong immune response that, in genetically susceptible individuals, may contribute to the onset of autoimmune conditions. Some researchers propose that the body’s attempt to combat the Borrelia infection may inadvertently set off inflammatory or autoimmune processes, potentially including Hashimoto’s (Klempner et al., 2001).

Molecular Mimicry: A Case of Mistaken Identity

One of the most discussed theories is molecular mimicry, where the immune system confuses the proteins of the Lyme bacteria with those of the thyroid gland. This cross-reactivity may cause the immune system to attack thyroid tissue, mistaking it for an infectious threat (Chmielewska-Badora et al., 2000).

Symptom Confusion

Both Hashimoto’s and chronic Lyme disease present with overlapping symptoms—fatigue, cognitive dysfunction (“brain fog”), joint stiffness, depression, and cold sensitivity—making it difficult to discern one condition from the other without careful investigation. Misdiagnosis or delayed diagnosis is common when symptom patterns blur the lines between infection and autoimmunity (Stricker & Fesler, 2018).

Systemic Inflammation and Hormonal Disruption

Lyme disease can generate widespread inflammation that disrupts endocrine function. The thyroid, being highly sensitive to immune signals, may respond to this inflammation with impaired hormone production. Additionally, systemic infections can throw off hormonal feedback loops, contributing to thyroid irregularities or exacerbating existing autoimmune responses (Rapoport, 2012).

---

The Role of Ultrasound in Diagnosis and Monitoring

Thyroid ultrasound imaging has become an essential, non-invasive tool in evaluating the thyroid gland in both Hashimoto’s and Lyme-related presentations. High-resolution ultrasound can detect structural changes in the thyroid—such as tissue heterogeneity, gland enlargement, or nodules—that may be missed by standard blood tests alone.

In patients with suspected autoimmune thyroiditis or lingering inflammatory symptoms following Lyme exposure, ultrasound offers valuable real-time insights into the condition of the thyroid tissue. Specific signs such as reduced echogenicity (indicating inflammation), irregular margins, or altered vascular patterns can help support a diagnosis of Hashimoto’s or flag abnormalities that warrant further investigation (Iannuccilli et al., 2004).

In advanced integrative practices, ultrasound is also used for tracking disease progression, evaluating treatment response, and distinguishing between autoimmune damage and other thyroid-related pathologies. It is especially useful in individuals who present with persistent symptoms despite normal lab results—providing a visual validation of subclinical or silent inflammation.

---

Key Clinical Considerations

·        Evolving Science: While a causal link between Lyme disease and Hashimoto’s has not yet been definitively established, the immunological interplay is gaining more attention in clinical circles. More longitudinal and molecular studies are needed to confirm this relationship.

·        Diagnostic Strategy: For patients with a Hashimoto’s diagnosis and a history of tick exposure or chronic systemic symptoms, clinicians may consider expanded testing for Lyme disease and incorporate thyroid ultrasound as part of a comprehensive assessment.

·        Treating the Root: Functional and integrative medicine practitioners often look beyond symptom management to identify infectious, toxic, or inflammatory contributors to autoimmune dysfunction. Addressing potential Lyme infections may support thyroid recovery and symptom reduction in select patients.

---

AFTERTHOUGHT: A NOTE TO CARE STRATEGISTS
By: Dr. Angela Mazza - Integrative Endocrinologist

Lyme disease patients can be a challenging patient group - without a doubt!  Chronic infections like Lyme disease may act as environmental triggers for autoimmunity through mechanisms such as molecular mimicry, immune system dysregulation, and persistent inflammation. In certain genetically predisposed individuals, the immune response to Borrelia may cross-react with thyroid antigens such as thyroid peroxidase (TPO), promoting the production of thyroid autoantibodies and eventual thyroid tissue damage. Also, this chronic immune activation, that is often seen in post-treatment Lyme disease syndrome (PTLDS), may contribute to a Th1-dominant immune profile, which is frequently associated with autoimmune thyroid conditions. As clinicians, we should consider autoimmune thyroid screening in patients with persistent symptoms after Lyme disease, especially fatigue, cold intolerance, or weight gain, which overlap with hypothyroid presentations.

---

References

·        Chmielewska-Badora, J., Cisak, E., Wójcik-Fatla, A., Zwoliński, J., & Dutkiewicz, J. (2000). Lyme borreliosis and autoimmune diseases. Annals of Agricultural and Environmental Medicine, 7(2), 183–186.

·        Iannuccilli, J. D., Cronan, J. J., & Monchik, J. M. (2004). Risk for malignancy of thyroid nodules as assessed by sonographic criteria: The need for biopsy. Journal of Ultrasound in Medicine, 23(11), 1455–1464.

·        Klempner, M. S., Hu, L. T., Evans, J., Schmid, C. H., Johnson, G. M., Trevino, R. P., ... & Weinstein, A. (2001). Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. New England Journal of Medicine, 345(2), 85–92.

·        Rapoport, B. (2012). Mechanisms of autoimmunity in Graves’ disease and Hashimoto’s thyroiditis. Endocrinology and Metabolism Clinics, 41(4), 849–860.

·        Stricker, R. B., & Fesler, M. C. (2018). Chronic Lyme disease: A working case definition. Chronic Diseases International, 5(1), 1–6.

 

 

 

 

Dr. Robert Bard Leads a Diagnostic Revolution: Fusing Thermography and Ultrasound to Detect Disease Without Biopsies

WPIX11 News Health Feature | Reported from Midtown Manhattan / Marvin Scott

Introduction:
In the heart of Midtown Manhattan, diagnostic imaging is being reimagined by one of the field’s most innovative minds. Dr. Robert Bard, a seasoned radiologist and founder of Bard Diagnostic Imaging, is reshaping the standard of care through a pioneering integration of medical thermography and diagnostic ultrasound. Described as a “medical detective,” Dr. Bard is championing the use of non-invasive technologies to replace painful and often unnecessary biopsies—offering patients a faster, safer, and more comprehensive diagnostic experience.

Integrative Imaging in Action: Thermography as the First Line of Defense
Dr. Bard begins his diagnostic process using thermal imaging—a modality that detects heat patterns and blood flow changes in the body. These colorful, high-resolution scans have become invaluable tools in identifying abnormalities that might be missed by traditional lab tests or physical exams.

“What we do is a thermogram to find the area that's suspicious,” explained Dr. Bard. “Then we go right to diagnostic ultrasound to see what's really going on.” In one example, thermal imaging revealed a temperature asymmetry in a patient’s thyroid. The darker hue on one side indicated poor blood flow, suggesting the presence of fibrosis or a cyst—something completely overlooked in prior lab work.

Ultrasound: Precision Validation That Prevents Unnecessary Procedures
Once thermography flags a potential issue, Dr. Bard transitions immediately to ultrasound imaging for confirmation. Using real-time, high-resolution scans, he was able to verify the presence of fibrotic scarring consistent with chronic thyroid disease. This insight allowed for prompt treatment with thyroid hormone therapy—without the need for an invasive biopsy.

“This will avoid a biopsy because now you can treat the patient based on what we see,” said Dr. Bard. “This is what real precision medicine looks like.”

A Grateful Patient, A Life-Altering Discovery
Patient Roberta Morris, who had long sought answers about her symptoms, expressed deep gratitude for the discovery. “This is a non-invasive way, so that’s the better way,” she said. “None of my other doctors ever suggested this, and today we confirmed that there really is an issue with my thyroid. I’m very grateful that it was caught early.”

Revealing What Others Miss: Breast Cancer and Thyroid Scarring
Dr. Bard's practice is filled with case studies that affirm the diagnostic power of thermal imaging. In one instance, thermography detected a malignant tumor that had been missed by mammography. In another, it revealed thyroid scarring that went undiagnosed until it was too late. “This is a way of looking at disease non-invasively,” said Dr. Bard. “We can see if a patient really needs a biopsy—or if they don’t.”

Despite its success, thermography remains underutilized in the United States due to a lack of insurance coverage. Nevertheless, Dr. Bard continues to advocate for its role in preventive care and integrative diagnostics.

Conclusion: A Visionary in the New Era of Diagnostic Imaging
With hundreds of documented successes and a growing international following, Dr. Robert Bard stands at the forefront of a new era in diagnostic medicine. His innovative fusion of thermography and ultrasound is not only redefining clinical protocols but also offering patients a gentler, smarter path to answers. As healthcare moves toward more personalized and non-invasive approaches, Dr. Bard’s contributions are proving to be nothing short of revolutionary.

___________________________________________________________________________________

Reclaiming Midlife Health: A Call for Modern, Intuitive Women’s Care                                 

By: Roberta Morris / Edited by: Lennard Goetze, Ed.D & Graciella Davi

Introduction: A Personal Wake-Up Call
I didn’t set out to rethink the state of women’s healthcare—I simply booked a diagnostic visit. What I found, however, was more than a medical evaluation. During a recent appointment with Dr. Robert Bard, a radiologist in New York known for his integrative approach, I encountered something rare: a provider who views the body as a system, the patient as a partner, and technology as a means to deeper understanding—not just a tool for confirming disease.

The visit was revealing in more ways than one. Through non-invasive Doppler imaging, Dr. Bard identified irregularities in my thyroid—an organ that had never been examined closely in my past checkups. But what stood out wasn’t just the technology. It was the philosophy. It was the understanding that midlife health, especially for women, can—and must—be treated with greater precision, respect, and foresight.

Section I: Midlife Health Isn’t a Footnote—It’s a Frontier
Midlife for women brings transformation on nearly every physiological level. And yet, mainstream medicine too often treats menopause as a short-term inconvenience, rather than a long-term hormonal shift that affects cardiovascular health, brain function, bone density, immune response, and more.

The common narrative is reductionist: treat the symptoms, ignore the source. Hot flashes? Try hormone therapy or tough it out. Fatigue? Probably just stress. Weight gain? Eat better. Rarely is a deeper investigation pursued—one that considers how estrogen decline impacts every cell in the body. For millions of women, this fragmented care leads to misdiagnoses, untreated conditions, and a loss of trust in the healthcare system.

Section II: Beyond Band-Aids—A Blueprint for Better Care
Dr. Bard’s practice, though singular, provides a model worth emulating. By applying functional medicine principles—early detection, systems thinking, and individualized care—he demonstrates how modern medicine can evolve without abandoning science.

At his facility, technology is used not just to diagnose, but to understand. Tools like Doppler ultrasound can catch thyroid irregularities or vascular concerns before symptoms manifest. This isn’t just innovation for innovation’s sake; it’s a quiet revolution in how we define “preventative care.”

The real lesson from my visit wasn’t about one practitioner’s brilliance. It was about what happens when care is curious, not just clinical—when a provider asks why something is happening, not just what.

Section III: Intuition, Empathy, and the Future of Women’s Health
What women in midlife need isn’t more prescriptions—they need more precision, more listening, and more leadership from providers who understand the nuances of female physiology. Care must be both holistic and high-tech. It must account for how lifestyle, environment, and genetics converge.

That requires training. It requires mentorship. It requires more providers like Dr. Bard—but more importantly, it requires that we learn from such models and push for systemic upgrades. Women shouldn’t have to stumble into exceptional care. It should be the standard.

Conclusion: Midlife as a Catalyst for Change
My appointment with Dr. Bard opened my eyes—not just to the state of my thyroid, but to the broader state of women’s healthcare. It exposed gaps I didn’t know existed and illuminated what’s possible when care is deeply human and deeply informed.

Midlife doesn’t have to be a slow unraveling. It can be a powerful reset. But only if the systems meant to support us evolve with us. It’s time to modernize care for women—not by offering more quick fixes, but by rethinking the very foundations of how we listen, diagnose, and heal.

Unseen Warriors: Cheri Ambrose and the Global Fight Against Male Breast Cancer

By: Lennard M. Goetze, Ed.D

Introduction:
In the vast world of cancer advocacy, few have dared to champion a cause so overlooked, so misunderstood, and so deeply stigmatized. Yet, from the shadows of silence and misdiagnosis emerged a fearless voice—Cheri Ambrose. With unwavering determination and boundless compassion, she has dedicated over a decade to shining a light on a rarely spoken truth: men get breast cancer too. As the founder and driving force behind the Male Breast Cancer Global Alliance, Cheri has transformed personal conviction into a worldwide movement of awareness, support, and lasting change.

Champion of the Voiceless: A Legacy of Bold Compassion
Cheri Ambrose is not a breast cancer survivor herself, but her deep empathy and fierce sense of justice have propelled her to become one of the most important voices in male breast cancer advocacy today. Her story is one of resilience, advocacy, and most of all, humanitarianism. Since 2013, Cheri has committed herself to bringing a voice to those who were silenced by stigma, isolated by fear, or dismissed by systems rooted in bias.

What began as quiet outreach and a desire to fill an information void soon evolved into a full-fledged mission. As she met more men and families grappling with the confusion of a “women’s disease” diagnosis, Cheri saw the devastating effects of societal misunderstanding: late diagnoses, lack of access to clinical trials, emotional alienation, and a complete absence of male representation in public health discussions. For many of these men, Cheri became their first source of validation—and their fiercest advocate.

In 2014, recognizing the urgent need for a centralized resource and community, Cheri founded the Male Breast Cancer Coalition (MBCC), a first-of-its-kind virtual haven for male survivors, caregivers, medical professionals, and advocates. What started as a grassroots initiative quickly gained national attention. The coalition became a beacon for those living in silence, providing not only practical information but also human connection and hope.

By November 2021, the MBCC had grown into a global network, prompting the formation of the Male Breast Cancer Global Alliance (MBCGA). This evolution reflected both the rising number of voices joining the cause and the growing credibility of Cheri’s leadership in the medical and advocacy communities. MBCGA expanded its focus to include not just support, but also scientific collaboration, research advancement, and clinical inclusion. Under Cheri’s guidance, MBCGA now connects survivors, researchers, clinicians, and pharmaceutical leaders from around the world to revolutionize care for men with breast cancer.

Cheri’s humanitarian work doesn’t stop at awareness—it takes tangible form in systemic change. She has been a leading force in persuading pharmaceutical companies to include men in the labeling of breast cancer medications once thought suitable only for women. Through persistence and strategic partnerships, she has opened the door for men to be included in clinical trials, long denied to them due to outdated gender assumptions. Her work not only helps save lives—it rewrites the rules of inclusion in modern medicine.

Advertisement

Mentoring a Movement & Shaping the Next Generation of Advocates
More than an advocate, Cheri is a mentor and mobilizer. She has trained and developed hundreds of survivor representatives—men who now share their stories in hospitals, classrooms, government hearings, and international summits. These men, once voiceless, are now empowered leaders in their own right, thanks to Cheri’s vision and coaching. Their voices form a chorus that breaks through stigma, reshaping public understanding one conversation at a time.

In recognition of her tireless work, Cheri was awarded the Heart of Advocacy honor by the National Consortium of Breast Centers. This prestigious award reflects not just her achievements, but the genuine passion and humanity she brings to every aspect of her mission.

Beyond advocacy, Cheri plays a critical role in the broader cancer awareness movement. As Co-Editor of the New York Cancer Resource Alliance (NYCRA), she contributes to and curates a variety of health and wellness publications including Prevention101.org, NYCRA News, Health Scan News, and First Responders Health Report. Her writing and editorial work amplify her mission, reaching a wide array of professionals, patients, and policy-makers with essential health information and survivor stories.

Cheri is also a graduate of the National Breast Cancer Coalition’s PROJECT LEAD program, and she continues to serve as a key presence at major health summits such as the National Comprehensive Cancer Network Summit, ASCO, SABCS, and the ABC Global Conference in Lisbon. At each of these platforms, she represents not only male breast cancer patients, but all those fighting for recognition and equality in healthcare.

Building a Global Network of Support
Under Cheri Ambrose's leadership, the MBCGA has cultivated a robust network of partnerships with organizations dedicated to providing comprehensive support for men diagnosed with breast cancer. These collaborations aim to address the multifaceted needs of patients, from emotional support to financial assistance.

Financial Assistance through The CARE Project
Recognizing the financial burdens that often accompany a cancer diagnosis, the MBCGA partners with The CARE Project, Inc., a nonprofit organization founded by a breast cancer survivor. The CARE Project's MEN 2 Program offers financial assistance to male breast cancer patients, covering essential expenses such as insurance co-pays, utilities, rent, groceries, fuel, and transportation to and from treatment. This support allows patients to focus on healing without the added stress of financial hardship. 

Educational Resources and Awareness Campaigns
To promote early detection and awareness, the MBCGA has developed multilingual Self-Exam Cards for Men, available in nine languages, including English, Spanish, French, Italian, Dutch, German, Portuguese, Hebrew, and Polish. These cards provide easy-to-follow diagrams and instructions, highlighting warning signs and risk factors specific to men. The initiative is supported by pharmaceutical companies such as Daiichi Sankyo, Inc., Lilly, and Pfizer.

The MBCGA collaborates with leading healthcare institutions to advance research and clinical trials focused on male breast cancer. By bringing together patients, researchers, clinicians, and oncologists, the alliance aims to improve treatment options and outcomes for men diagnosed with the disease. 

In its mission to provide holistic support, the MBCGA partners with organizations such as Imerman Angels, which offers one-on-one support to cancer patients and caregivers through a network of trained Mentor Angels. These mentors provide emotional support and guidance, helping patients navigate their cancer journey. Additionally, the alliance collaborates with Learn Look Locate, an organization dedicated to breast cancer education and support. Together, they work to increase awareness, provide educational resources, and connect patients with support networks. 

Conclusion:

Cheri Ambrose’s legacy is not defined by accolades or titles—it is defined by lives changed, silences broken, and injustices righted. In a world where the voices of the marginalized are often drowned out, she has become a force of amplification. Her compassion is bold. Her fight is personal. Her impact is global.

She has stood up for those who were told they didn’t belong in the breast cancer narrative, and through her, they now have not only a place—but a platform. From living rooms to research labs, from local communities to international health councils, Cheri has made one thing clear: breast cancer doesn’t discriminate, and neither should we.

Cheri Ambrose is more than an advocate. She is a changemaker, a humanitarian, and a beacon of hope for those navigating the darkest moments of their lives. In giving a voice to the voiceless, she has forever changed the story of male breast cancer—for the better.

_________________________________________________________________________________

Sponsor

For more information about the MALE BREAST CANCER GLOBAL ALLIANCE PREDISPOSITION TESTING PROGRAM, contact us at: www.mbcglobalalliance.org or contact our hotline at: 516.522-0777

 --------------------------------------------------------------------------------------------------------------------------

THIS MESSAGE IS BROUGHT TO YOU BY THE MALE BREAST CANCER GLOBAL ALLIANCE

The Male Breast Cancer Global Alliance (MBCGA) is leading the charge in awareness, education, and support for men affected by this disease. This organization has built a worldwide network of survivors, advocates, researchers, and healthcare professionals working to shatter the stigma and silence surrounding male breast cancer. They’ve played a crucial role in pushing for more inclusive research, advancing public health messaging, and ensuring men have access to the resources they need. Through tireless advocacy and collaboration, MBCGA has helped get male breast cancer recognized in global cancer policy and has elevated the voices of countless survivors. Their data-driven campaigns and survivor-led storytelling have reached millions, and their partnership with Bard Diagnostics is all about scaling that impact through accessible genetic testing.

  --------------------------------------------------------------------------------------------------------------------------

RELATED RESOURCES

Under a dedicated partnership with the Male Breast Cancer Global Alliance, BARDDIAGNOSTICS established key programs including: EARLIER DETECTION, PREDISPOSITION GENE TESTING, FIGHT RECURRENCE, ACTIVE SURVEILLANCE AND THE 2ND OPINION SCAN. For the many MEN who seek a significantly improved lifestyle or an upgrade in personalized healthcare, getting better answers about your state of health is paramount and IT ALL STARTS WITH STATE OF THE ART DIAGNOSTICS. The visionary paradigm that makes up true personalized medical care involves the integration between modalities, a collaboration between specialists and an upgrade in their strategic approach and you'll find it all at BardDiagnostics. 

 --------------------------------------------------------------------------------------------------------------------------

UNCOVERED – Shedding Light on Male Breast Cancer
The first official newsletter from the Male Breast Cancer Global Alliance, launched in proud partnership with AngioMedical Media and the Integrative Cancer Resource Society. Rooted in the belief that education is power, UNCOVERED delivers essential news, scientific updates, and survivor stories to inform and inspire. Each issue is packed with the latest in male breast cancer research, treatment innovations, and advocacy efforts from around the globe. Whether you're a patient, caregiver, or medical professional, UNCOVERED is your trusted source for facts and forward-thinking perspectives. Join us in uncovering the truth—and empowering lives through knowledge. (visit our regularly updated Newsletter)

 --------------------------------------------------------------------------------------------------------------------------

The INTEGRATIVE CANCER RESOURCE SOCIETY is a self-funded (Linkedin Based) independent volunteer group of non-profit foundations/charities, researchers, educators, community leaders and survivors. Under the spirit of collaboration and partnership, we are joined to bring a new level of support to cancer patients, survivors and all those seeking current information about cancer care. We form a unique network of support for one another- while driven to help those who need additional resources, technical updates or empowerment on the road to recovery. ICRS uses the power of the "interweb" to reach a global audience and a network of resources beyond our local borders. We have engaged some of the most impressive minds, perspectives and resources and enjoyed the exchange of vital information that is useful to all. Thanks in part to digital collaboration, these "foreign" connections have always been a part of our cancer crusade, now joining us in what we call "BORDERLESS MEDICINE".

 --------------------------------------------------------------------------------------------------------------------------

In great support of a the global movement of NON-INVASIVE medicine, we proudly introduce the INTEGRATIVE HEALTH RESEARCH CENTER by AngioInnovation Research (501c3). This New York city-based diagnostic imaging validation lab is established to clinically identify the efficacy, performance and supportive claims set by non-invasive therapeutics and diagnostic solutions. Co-founded by Dr. Robert L. Bard, the IHRC offers a non-profit, non-commercialized testing option for health-related innovations who seek an independent and impartial reporting through single-case pilot studies or IRB-Based clinical trials. The IHRC employs credentialed medical professionals and specialists in clinical research whose experience contributes to the unique strategic approach of each test study. (Visit: the AngioInstitute website)

LASER GUIDED VSELs- A Patient's Journey to Restorative Medicine

KINESIOLOGICAL ANALYSIS:  VSELs TREATMENT PROGRESS EXPLAINED

By:  Matthew Einsohn, ND

This might seem like a small thing, but it's actually a big deal. When you're sitting, lifting your leg involves working against gravity, which is already challenging. But when you're lying down, it requires a whole different set of muscles and coordination. It means engaging not just the hip flexors but also the core and stabilizing muscles of the lower back and pelvis. This shows his overall muscle function and coordination have significantly improved.

Without the help of gravity, his core muscles have to work even harder to stabilize and support the movement. This improvement in core strength is great news. Plus, this movement indicates improved flexibility and range of motion, likely due to decreased muscle stiffness and better neuromuscular control.

Being able to perform this movement both sitting and lying down means his nervous system and muscles are working together more effectively. This is crucial for overall mobility and daily activities.

When Dr. Blatman is discussing the origins of pain, which is associated with sheer force and pressure, it appears that stabilization has been achieved. Based on watching the video (above) several times, I would theorize that significant restoration is occurring. It seems he has addressed the root cause of the pain by restoring the integrity of the fascia.

Additionally, while there is a notion that one can make injuries less noticeable, this approach does not seem to align with his method. Instead, if he is indeed focusing on restoring the integrity of the fascia, it suggests that he is addressing the fundamental issue underlying the pain rather than merely masking the symptoms.

Some conditions just this mechanism can help with:

* Muscle weakness and atrophy from post-stroke rehabilitation or muscle degenerative diseases
* Neurological disorders such as MS or Parkinson's
* Recovery from spinal injuries
* Any chronic pain such as Fibromyalgia
* Anyone with joint or mobility problems

Muscle Weakness and Atrophy: Conditions causing muscle weakness or atrophy, such as post-stroke rehabilitation or muscle degenerative diseases, might see improvements in strength and coordination with similar treatments.

Neurological Disorders: Disorders like multiple sclerosis or Parkinson's disease, where muscle control and coordination are affected, could benefit from enhanced muscle function and coordination.

Post-Surgical Rehabilitation: Recovery from surgeries, especially orthopedic or spinal surgeries, could be supported by treatments that improve muscle strength, flexibility, and functional movement.

Chronic Pain Conditions: Conditions like fibromyalgia or chronic back pain that involve muscular and structural issues might see relief through better muscle engagement and reduced stiffness.

Balance and Stability Issues: Treatments that enhance core strength and overall muscle coordination can help with balance and stability, which is crucial for individuals with vertigo or balance disorders.

Joint and Mobility Problems: For conditions like arthritis or other joint issues, improving range of motion and muscle strength can reduce pain and enhance mobility.

Sports Injuries: Athletes recovering from injuries might benefit from improved muscle function and coordination, aiding in a quicker and more effective recovery.

---

THE BACK STORY: 

VSELs by definition are Very Small Embryonic-Like Stem cells.  They are rare stem cells found in adult tissues that may have potential in regenerative medicine. They are slightly smaller than red blood cells and are located in the inner cell mass of the blastocyst during early development. VSELs are quiescent but can be activated during stress and mobilized into peripheral blood. They have a distinct morphology with a high nuclear/cytoplasmic ratio and undifferentiated chromatin. VSELs also express markers of pluripotent stem cells, such as Oct4, Nanog, and SSEA, and markers of primordial germ cells (PGCs), which suggests they may be related to PGCs. 

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461217/

PROCEDURE REPORT: DR. BLATMAN'S TRANSCRIPT ON DR. BARD'S VSELs TREATMENT DAY 1

Dr. Bard and I started the procedure with a deep discussion, making sure we had his wish list and an understanding of what he was specifically wanting and trying to get better. By the time we proceeded, we drew eight tubes of blood, we spun it down, and concentrated his plasma. And then we lasered that plasma and prepared the VSELs out of the solution, activating dormant, very small embryonic like stem cells from his blood -dormant since his birth. And then we prepared them for injection into him. We used eight syringes of these VSELs to inject specific parts of him. There were tendons anchoring his right quadriceps. There were tendons anchoring both of his butt muscles. There were muscles and tendons anchoring the end of his quadriceps that help him control his knee whose weakness brings him knee pain.

I believe he (Dr Bard) was able to tell that when we were doing that needle surgery to place the VSELs so they could facilitate repair of the injured fascia anchors, he could tell that the needle was in the right place. When you've experienced this pain for so long and you can feel what's going on inside your body, you have a way of knowing that I'm in the right spot. And since this procedure can be very uncomfortable, he was able to breathe nitrous oxide which greatly reduces discomfort and anxiety. This made the process a whole lot less uncomfortable for him. And then we followed the needle surgery with an intravenous injection giving him a little more than 40 CCs of the VSELs derived from his blood. These were given intravenously along with an ozone IV at the same time. So the “babies were piggybacked” into the ozonated blood IV after his blood went through ultraviolet light to clean it. As these cells were going into his body, we used a SONG modulated laser to guide these cells to where we want them to get stuck and where we want them to do their work. And so we sent these to his brain, to his cerebellum and balance centers, down his spinal cord, and then into his right thigh.

I'm hoping to see if this technology could reactivate some of the nerves that were damaged from the polio, because when polio damages nerves, it doesn't interrupt or cut them. They're still there, they just don't work. So we're hoping that they're still there enough that we can coax them to work or coax them to health. And we don't know if there's a chance to do that or not, because to the best of my knowledge, this has never been done before (with Post-Polio syndrome). So we are the first ones I would think, to use VSELs in polio for the regeneration of the nervous system and to see if it would work.

When we inject into joints, you can see the cartilage vertical dimension increase. When you inject into rotator cuff tendon, you can subsequently see with ultrasound that the tendon defect filled in. You can also see it on MRI that the defect in the tendon filled in.

We have some patients with Parkinson's in the treatment group from this laser that have shown improvement in 30 minutes. So it can happen pretty quickly. It can also take two or three months before you see a change. You never know.

---

2024 MEDICAL INNOVATOR: MEET DR. HAL BLATMAN 

Introduction: In the continued search for innovative healers and luminaries in the world of wellness, the Integrative Pain Healers Alliance honors professionals who conduct clinical leadership in their daily practice.  These role models inspire and pave the way for others within their generation to advance their education and expand their capacity in their selected healing arts, or explore other modalities that add to their ability to help their patients.

Our directors and publishers have reviewed the integrative work of Dr. Hal Blatman.  We recognize his holistic & innovative philosophies, his intuitive clinical approach and his expansive vision to engage in what his patients and colleagues would consider “the most sensible and intelligent solutions”.

With dual locations in Cincinnati, Ohio and NYC, Dr. Blatman founded the Blatman Health and Wellness Center- offering a variety of the latest protocols and modalities. His featured health services include: Regenerative Medicine (Stem Cell therapy & PRP), Pain Management and IV Therapy.  Dr. Blatman has also established a successful history working with patients with complex medical disorders by exploring a wider set of diagnostic and therapeutic options and exploratory solutions which includes Metabolic Terrain Medicine for those with cancer. He is also certified in the ReCODE program from Apollo Health for those with dementia and Alzheimer's Disease.

"THE BLATMAN METHOD"

Over the course of more than 30 years in clinical practice Dr. Blatman has developed The Blatman Method – a well published strategy for Understanding and Treating Pain. This method is based on 5 rules:

1. You cannot believe pain comes from where you feel it. Your headache does not come from your head, blood vessels or nerves. Pain in your left arm could be a heart attack, and knee pain does not come from the joint, evidenced by persistent knee pain long after joint replacement surgery.

2. It is not important to distinguish what you think the pain feels like. In fact, your brain cannot tell the difference between sharp, dull, achy, stabbing, numbness, tingling, burning, and more. They all can have the same cause.

3. The only thing you can really believe is what you can touch and feel, and where you are specifically tender, millimeter by millimeter, is where your fascia is kinked or tied in a knot, or where your fascia anchors to hold you together and you have injured and repaired this hundreds of times.

4. If you are examined this way looking for where you are tender from head to toe, the places where you are overall most tender represent the kinks and injuries from your lifetime that generate most of the pain of which you are conscious.

5. No matter how long you have had the pain, and no matter what you have been told is your diagnosis – as quickly as you unkink your fascia and get your body to regrow and strengthen to hold together better on the inside – the pain you had will already be gone.

REGENERATIVE MEDICINE 

Dr. Blatman has been helping people recover and restore worn joints and avoid joint replacement surgery for more than 30 years. His patients have seen great success with regenerative and holistic therapies for pain. Regenerative medicine therapies include Peptide therapy, Platelet-Rich-Plasma (PRP) Therapy, Stem Cell Therapy, exosome treatments, and vSEL Therapy.

Painful and degenerative joints aren’t nearly the only applications of regenerative medicine:

• Tendon repair – Rather than cutting and anchoring injured tendons with surgical repair, regenerative techniques involve reinjuring the tendon with a needle surgery technique and injecting growth factors that facilitate biologic repair of the tendon.

• Ligament repair – Rather than cutting and anchoring injured ligaments with surgical repair, regenerative techniques involve reinjuring the ligament with a needle surgery technique and injecting growth factors that facilitate biologic repair of the ligament

• Joint cartilage restoration – Rather than replace a worn joint via invasive surgery, use the idea that our bodies restore cartilage from daily wear and tear minute by minute, and enhance this process with glucosamine, peptides, PRP, and stem cells.

• Sexual dysfunction treatment – Regenerative medicine techniques may involve injecting growth factors (PRP/stem cells) into intimate areas to regenerate blood vessels and nerves that bring improvement with engorgement and sensation.

• Pelvic floor repair – Growth factor injection and radiofrequency treatments can reduce urinary stress incontinence in women by aiding in repairing and strengthening the pelvic floor and associated muscles.

• Pelvic pain recovery – Regenerative treatments can be used in addition to physical therapy to facilitate repair of fascia that anchors pelvic, gluteal, and thigh muscles. This includes chronic pain generally attributed to the pudendal nerve.

• Heart repair – When heart function has been lost from injuries like ablation and heart attacks, laser-activated and SONG modulated laser-guided vSELS (very small embryonic-like stem cells) can restore heart function and have even gotten people off the heart transplant list.

• Lung repair – Stem cell therapies have been used for more than 10 years to help restore lung tissue and function in people with degenerative lung conditions like COPD and emphysema.

• Neurorehabilitation – Part of our treatment for neurological disorders includes peptides and IV injections of laser activated and laser guided vSELS (very small embryonic like stem cells). We have seen improvements in people with MS, Parkinson’s, and Alzheimer’s.

BIO & BACKGROUND: 

HAL BLATMAN, MD, DAAPM, ABIHM

Dr. Blatman is a nationally recognized specialist in treating myofascial pain. He is credentialed in Pain Management and Board Certified in Occupational and Environmental Medicine and in Integrative Medicine. Dr. Blatman is a Past-President of the American Holistic Medical Association. After receiving his medical degree from the Medical College of Pennsylvania in 1980, Dr. Blatman completed two years of training in orthopedic surgery. He later studied clinical toxicology and ergonomics during his residency in Occupational and Environmental Medicine at the University of Cincinnati Hospital. For several years, Dr. Blatman practiced family medicine while managing a chain of urgent care facilities. During Dr. Blatman’s tenure in general medicine, he recognized standard of care medicine’s difficulty treating and managing chronic and myofascial pain. In his search for answers he studied with the late Janet Travell, MD, then recognized as the world’s leading expert in treating myofascial pain disorders. He now teaches doctors and other providers, and leads a clinical team that understands that pain generally comes from a lifetime of injuries to fascia, and by healing most of it can be made to go away.

For more information, visit Dr. Blatman’s website at: www.blatmanhealthandwellness.com